$1.080
-0.020 (-1.82%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de LCTX por análisis de gráficos similares
Alphio's LCTX stock price prediction model matches the current Lineage Cell Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.08 (+0.22%). The 1-week path is $1.05 (-3.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Lineage Cell Therapeutics Inc?
Lineage Cell Therapeutics Inc (LCTX) appears to be a good buy right now due to its current price of $1.11, which is significantly below the analyst price target of $9 from Canaccord. Additionally, the gross margin stands at an impressive 100% for the most recent quarter, indicating strong profitability potential. However, the main risk is the forward P/E ratio of 30.67, suggesting that the stock may be overvalued based on future earnings expectations.
LCTX cerró en $1.08 el Tuesday, tras bajar -1.82%
Lineage Cell Therapeutics Inc (LCTX) last closed at $1.08, losing -1.82%. These facts feed the 1-day and 1-week LCTX price prediction above.
Factores de la previsión
Los factores de la previsión de Lineage Cell Therapeutics Inc (LCTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de LCTX, ordenadas por similitud.
Análisis de estacionalidad de LCTX
Historically the probability of a positive September return for LCTX is 50.00%. January offers the highest probability of a positive month at 72.13%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de LCTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $0.80 | $1.01 | $1.27 | -6.12% |
| Oct 2026 | $1.24 | $1.27 | $1.54 | +17.75% |
| Nov 2026 | $0.99 | $1.10 | $1.33 | +1.86% |
| Dec 2026 | $1.09 | $1.34 | $1.35 | +23.80% |
En 2026, se proyecta que Lineage Cell Therapeutics Inc (LCTX) oscile entre $0.80 y $1.54.
Previsión mensual de Lineage Cell Therapeutics Inc para 2026
En Sep de 2026, se proyecta que Lineage Cell Therapeutics Inc promedie $1.01, con un mínimo de $0.80 y un máximo de $1.27.
En Oct de 2026, se proyecta que Lineage Cell Therapeutics Inc promedie $1.27, con un mínimo de $1.24 y un máximo de $1.54.
En Nov de 2026, se proyecta que Lineage Cell Therapeutics Inc promedie $1.10, con un mínimo de $0.99 y un máximo de $1.33.
En Dec de 2026, se proyecta que Lineage Cell Therapeutics Inc promedie $1.34, con un mínimo de $1.09 y un máximo de $1.35.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.